Atlas Trials

Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma

Clinical trial NCT00019383 · COMPLETED

Trial details

NCT number
NCT00019383
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma (Skin)
Start date
1998-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.